Scott Thomas Jackson
CIK 1566617 · Chief Executive Officer · last filed 2026-05-20
Scott Thomas Jackson is a Chief Executive Officer who has filed 40 SEC Form 4 insider transactions across 5 companies since 2013. The most recent filing, for MGNX, was dated May 20, 2026. Across all open-market trades the lifetime net is +$57.6K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $272.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$272.2K
5
40
$57.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MGNX | Director | 14,750 | $3.96 | $58.4K | $0 | 12 | 2026-05-20 |
| MURAV | Director | — | — | — | $0 | 5 | 2025-12-05 |
| SPRO | Director | 75,000 | $2.85 | $213.8K | $0 | 7 | 2025-06-16 |
| CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Director | 5,250 | $15.70 | $82.4K | $0 | 7 | 2024-05-01 |
| Celator Pharmaceuticals Inc (CPXX) Delisted | Chief Executive Officer | 0 | — | — | $57.6K | 8 | 2016-07-12 |
Recent Filings
40 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-20 | MGNX | Mixed | +3,750 | $0 | EDGAR |
| 2025-12-05 | MURAV | Disp (D) | — | $0 | EDGAR |
| 2025-06-16 | SPRO | Grant (A) | +20,000 | $0 | EDGAR |
| 2025-06-13 | MURAV | Grant (A) | — | $0 | EDGAR |
| 2025-05-22 | MGNX | Mixed | +6,500 | $0 | EDGAR |
| 2024-06-05 | MURAV | Grant (A) | — | $0 | EDGAR |
| 2024-06-03 | MURAV | Grant (A) | — | $0 | EDGAR |
| 2024-05-30 | SPRO | Grant (A) | +20,000 | $0 | EDGAR |
| 2024-05-23 | MGNX | Grant (A) | — | $0 | EDGAR |
| 2024-05-22 | MGNX | Exer (M) | +4,500 | $0 | EDGAR |